| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communication |
From the Departments of Medical Genetics*
and
Pathology,
Haartman Institute, University of
Helsinki, the Finnish Institute of Occupational
Health,
and the Second Department of
Surgery,§
Helsinki University Central Hospital,
Helsinki, Finland
Germline mutations of LKB1/Peutz-Jeghers syndrome gene predispose carriers to hamartomatous polyposis of the gastrointestinal tract as well as to cancer of different organ systems. Although Peutz-Jeghers syndrome patients frequently present with neoplasms of the colon, stomach, small intestine, pancreas, breast, ovaries, and cervix, somatic mutations appear to be rare in the sporadic tumor types thus far studied (colorectal, gastric, testicular, and breast cancers). To evaluate whether somatic mutations of LKB1 contribute to the tumorigenesis of yet unstudied tumor types, we screened 14 cell lines and 129 tumor specimens from different cancers for a genetic defect in LKB1. Six melanoma and eight myeloma cell lines were scrutinized for LKB1 somatic mutations by genomic sequencing. No changes were found in the coding LKB1 sequence and exon/intron boundaries. Next, we analyzed 12 pancreatic, 8 gastric, 12 ovarian granulosa cell, 26 cervical, 28 lung, 24 soft tissue, and 19 renal tumors by single-strand conformational polymorphism analysis. Three changes in LKB1 coding nucleotide sequence were identified. One base pair deletion at A957 and G958 substitution by T occurred in a cervical adenocarcinoma sample, resulting in a frameshift and premature stop codon at position 335. Substitution of A581 by T occurred in a lung adenocarcinoma sample, resulting in the change of aspartic acid at position 194 to valine. A loss of another allele was detected in this sample. One silent change, C1257T, was found in a pancreatic carcinoma sample. The changes were not present in the matched normal tissue DNA samples. Our results suggest that mutational inactivation of LKB1 is a rare event in most sporadic tumor types.
This article has been cited by other articles:
 |
|
 |
|
  M. FURUKAWA, A. YAMASAKI, J. YOSHIDA, M. TSUJINO, N. WAKABAYASHI, K. HONOKI, and T. TSUJIUCHI Mutations of LKB1 Gene in Pancreatic Ductal Adenocarcinomas Induced by N-Nitrosobis(2-oxopropyl)amine in Hamsters Anticancer Res, October 1, 2009; 29(10): 4047 - 4050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nath-Sain and P. A. Marignani LKB1 Catalytic Activity Contributes to Estrogen Receptor {alpha} Signaling Mol. Biol. Cell, June 1, 2009; 20(11): 2785 - 2795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Fan, C. Ma, and H. Zhang The molecular mechanisms that underlie the tumor suppressor function of LKB1 Acta Biochim Biophys Sin, February 1, 2009; 41(2): 97 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zhong, X. Liu, F. R. Khuri, S.-Y. Sun, P. M. Vertino, and W. Zhou LKB1 Is Necessary for Akt-Mediated Phosphorylation of Proapoptotic Proteins Cancer Res., September 15, 2008; 68(18): 7270 - 7277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. H. Lu, W. Wu, B. Dave, B. M. Slomovitz, T. W. Burke, M. F. Munsell, R. R. Broaddus, and C. L. Walker Loss of Tuberous Sclerosis Complex-2 Function and Activation of Mammalian Target of Rapamycin Signaling in Endometrial Carcinoma Clin. Cancer Res., May 1, 2008; 14(9): 2543 - 2550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Kim, H. K. Chung, K. C. Park, J. H. Hwang, Y. S. Jo, J. Chung, D. V. Kalvakolanu, N. Resta, and M. Shong Tumor Suppressor LKB1 Inhibits Activation of Signal Transducer and Activator of Transcription 3 (STAT3) by Thyroid Oncogenic Tyrosine Kinase Rearranged in Transformation (RET)/Papillary Thyroid Carcinoma (PTC) Mol. Endocrinol., December 1, 2007; 21(12): 3039 - 3049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Scott, S. Nath-Sain, M. D. Agnew, and P. A. Marignani LKB1 Catalytically Deficient Mutants Enhance Cyclin D1 Expression Cancer Res., June 15, 2007; 67(12): 5622 - 5627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Wagner, J. E. Mullally, and F. A. Fitzpatrick Reactive Lipid Species from Cyclooxygenase-2 Inactivate Tumor Suppressor LKB1/STK11: CYCLOPENTENONE PROSTAGLANDINS AND 4-HYDROXY-2-NONENAL COVALENTLY MODIFY AND INHIBIT THE AMP-KINASE KINASE THAT MODULATES CELLULAR ENERGY HOMEOSTASIS AND PROTEIN TRANSLATION J. Biol. Chem., February 3, 2006; 281(5): 2598 - 2604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ghaffar, F. Sahin, M. Sanchez-Cepedes, G. H. Su, M. Zahurak, D. Sidransky, and W. H. Westra LKB1 Protein Expression in the Evolution of Glandular Neoplasia of the Lung Clin. Cancer Res., August 1, 2003; 9(8): 2998 - 3003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Jimenez, P. Fernandez, O. Dominguez, A. Dopazo, and M. Sanchez-Cespedes Growth and Molecular Profile of Lung Cancer Cells Expressing Ectopic LKB1: Down-Regulation of the Phosphatidylinositol 3'-Phosphate Kinase/PTEN Pathway Cancer Res., March 15, 2003; 63(6): 1382 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sanchez-Cespedes, P. Parrella, M. Esteller, S. Nomoto, B. Trink, J. M. Engles, W. H. Westra, J. G. Herman, and D. Sidransky Inactivation of LKB1/STK11 Is a Common Event in Adenocarcinomas of the Lung Cancer Res., July 1, 2002; 62(13): 3659 - 3662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M M Entius, J J Keller, A M Westerman, B P van Rees, M-L F van Velthuysen, A F P M de Goeij, J H P Wilson, F M Giardiello, and G J A Offerhaus Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome J. Clin. Pathol., February 1, 2001; 54(2): 126 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L F Forster, S Defres, D R Goudie, D U Baty, and F A Carey An investigation of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers J. Clin. Pathol., October 1, 2000; 53(10): 791 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Trojan, A Brieger, J Raedle, M Esteller, and S Zeuzem 5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer Gut, August 1, 2000; 47(2): 272 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Launonen, E. Avizienyte, A. Loukola, P. Laiho, R. Salovaara, H. Järvinen, J.-P. Mecklin, A. Oku, M. Shimane, H. C. Kim, et al. No Evidence of Peutz-Jeghers Syndrome Gene LKB1 Involvement in Left-sided Colorectal Carcinomas Cancer Res., February 1, 2000; 60(3): 546 - 548. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. W. CHEN, E. AVIZIENYTE, S. ROTH, I. LEIVO, A. A MAKITIE, L.-M. AALTONEN, and L. A AALTONEN PTEN and LKB1 genes in laryngeal tumours J. Med. Genet., December 1, 1999; 36(12): 943 - 944. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tiainen, A. Ylikorkala, and T. P. Makela Growth suppression by Lkb1 is mediated by a G1 cell cycle arrest PNAS, August 3, 1999; 96(16): 9248 - 9251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Marignani, F. Kanai, and C. L. Carpenter LKB1 Associates with Brg1 and Is Necessary for Brg1-induced Growth Arrest J. Biol. Chem., August 24, 2001; 276(35): 32415 - 32418. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
